Concepedia

Publication | Open Access

Treatment of Splenic Marginal Zone Lymphoma With Rituximab Monotherapy: Progress Report and Comparison With Splenectomy

DOIFull Paper Access

87

Citations

32

References

2013

Year

Christina Kalpadakis, Gerassimos A. Pangalis, Maria K. Angelopoulou, Sotirios Sachanas, Flora N. Kontopidou, Xanthi Yiakoumis, Evagelia M. Dimitriadou, Maria Dimopoulou, Maria Moschogiannis, Penelope Korkolopoulou,
The Oncologist

Abstract

Rituximab is a very effective and well-tolerated therapy and may be substituted for splenectomy as the first-line treatment of choice for patients with SMZL.

References

YearCitations

Page 1